# Psyence Biomedical Ltd.

Type: Company (PBM)

Source: Startup Intelligence Brief — https://getstartupbrief.com/entity/psyence-biomedical-ltd
Canonical HTML page: https://getstartupbrief.com/entity/psyence-biomedical-ltd

## Timeline

- **2026-02-20**: Put Option Exercised — PsyLabs Ltd. formally exercises its rights under the Put Option Agreement with Psyence BioMed.
- **2026-02-20**: Strategic Investment Announced — Psyence BioMed announces it will make an equity investment in PsyLabs at fair market value.

## Recent coverage (1 stories)

### Psyence BioMed to Invest in PsyLabs Following Put Option Exercise
2026-02-21 00:41:18 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Psyence Biomedical Ltd. (Nasdaq: PBM) has announced a strategic equity investment in PsyLabs Ltd. after the manufacturer exercised its rights under a previously established put option agreement. This move strengthens the relationship between the biopharmaceutical developer and its primary supplier of nature-derived psychedelic compounds.
Full story: https://getstartupbrief.com/story/psyence-biomed-psylabs-equity-investment-put-option

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getstartupbrief.com/guides/methodology for the full editorial methodology.